The Efficacy of Denosumab for Prevention of Early Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty

Abstract

n 998 SHAO AND WU 14. Chapurlat R. Effects and management of denosumab discontinuation. Joint Bone Spine. 2018;85(5):515. 15. Anastasilakis AD, Papapoulos SE, Polyzos SA, Appelman-Dijkstra NM, Makras P. Zoledronate for the prevention of bone loss in women discontinuing denosumab treatment. A prospective 2-year clinical trial.